TreeWAS – Variant ID: rs17121944

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.014	0.986
L72.0 Epidermal cyst	0.014	0.986
T36-T50 Poisoning by drugs, medicaments and biological substances	0.013	0.987
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987
T43.2 Other and unspecified antidepressants	0.013	0.987
L72 Follicular cysts of skin and subcutaneous tissue	0.012	0.988
L80-L99 Other disorders of the skin and subcutaneous tissue	0.012	0.988
T43.3 Phenothiazine antipsychotics and neuroleptics	0.012	0.988
T43.0 Tricyclic and tetracyclic antidepressants	0.011	0.989
L60-L75 Disorders of skin appendages	0.011	0.989
L92 Granulomatous disorders of skin and subcutaneous tissue	0.011	0.989
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.011	0.989
T43.5 Other and unspecified antipsychotics and neuroleptics	0.011	0.989
L91 Hypertrophic disorders of skin	0.011	0.989
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.011	0.989
L91.8 Other hypertrophic disorders of skin	0.011	0.989
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.011	0.989
T46.4 Angiotensin-converting-enzyme inhibitors	0.011	0.989
T46.1 Calcium-channel blockers	0.011	0.989
Chapter XII Diseases of the skin and subcutaneous tissue	0.011	0.989
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.011	0.989
L89 Decubitus ulcer	0.010	0.990
S60-S69 Injuries to the wrist and hand	0.010	0.990
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.010	0.990
T43.9 Psychotropic drug, unspecified	0.010	0.990
T43.8 Other psychotropic drugs, not elsewhere classified	0.010	0.990
T43.6 Psychostimulants with abuse potential	0.010	0.990
T43.4 Butyrophenone and thioxanthene neuroleptics	0.010	0.990
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.010	0.990
L50-L54 Urticaria and erythema	0.010	0.990
L90 Atrophic disorders of skin	0.010	0.990
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.010	0.990
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.010	0.990
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.990
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.010	0.990
T41 Poisoning by anaesthetics and therapeutic gases	0.010	0.990
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990
T36 Poisoning by systemic antibiotics	0.010	0.990
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.010	0.990
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.010	0.990
S40-S49 Injuries to the shoulder and upper arm	0.010	0.990
S62 Fracture at wrist and hand level	0.010	0.990
L85 Other epidermal thickening	0.009	0.990
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.009	0.990
L81 Other disorders of pigmentation	0.009	0.990
L60 Nail disorders	0.009	0.991
S64 Injury of nerves at wrist and hand level	0.009	0.991
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991
T46.7 Peripheral vasodilators	0.009	0.991
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.991
T46.3 Coronary vasodilators, not elsewhere classified	0.009	0.991
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.991
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991
S90-S99 Injuries to the ankle and foot	0.009	0.991
T40.2 Other opioids	0.009	0.991
S70-S79 Injuries to the hip and thigh	0.009	0.991
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.009	0.991
L72.2 Steatocystoma multiplex	0.009	0.991
L89.2 Stage III decubitus ulcer	0.009	0.991
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.009	0.991
L90.0 Lichen sclerosus et atrophicus	0.009	0.991
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.009	0.991
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.009	0.991
T90 Sequelae of injuries of head	0.009	0.991
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.009	0.991
L53 Other erythematous conditions	0.009	0.991
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.009	0.991
L52 Erythema nodosum	0.009	0.991
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.009	0.991
L95 Vasculitis limited to skin, not elsewhere classified	0.009	0.991
L94 Other localised connective tissue disorders	0.009	0.991
L93 Lupus erythematosus	0.009	0.991
L87 Transepidermal elimination disorders	0.009	0.991
L88 Pyoderma gangrenosum	0.009	0.991
L86 Keratoderma in diseases classified elsewhere	0.009	0.991
L83 Acanthosis nigricans	0.009	0.991
L80 Vitiligo	0.009	0.991
L72.1 Trichilemmal cyst	0.009	0.991
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.009	0.991
S20-S29 Injuries to the thorax	0.008	0.991
L89.0 Stage I decubitus ulcer and pressure area	0.008	0.991
S64.4 Injury of digital nerve of other finger	0.008	0.992
S50-S59 Injuries to the elbow and forearm	0.008	0.992
L75 Apocrine sweat disorders	0.008	0.992
L74 Eccrine sweat disorders	0.008	0.992
L70 Acne	0.008	0.992
L68 Hypertrichosis	0.008	0.992
L67 Hair colour and hair shaft abnormalities	0.008	0.992
L66 Cicatricial alopecia [scarring hair loss]	0.008	0.992
L65 Other nonscarring hair loss	0.008	0.992
L64 Androgenic alopecia	0.008	0.992
L63 Alopecia areata	0.008	0.992
L62 Nail disorders in diseases classified elsewhere	0.008	0.992
L73 Other follicular disorders	0.008	0.992
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.008	0.992
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.008	0.992
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.008	0.992
L92.0 Granuloma annulare	0.008	0.992
S62.3 Fracture of other metacarpal bone	0.008	0.992
T33-T35 Frostbite	0.008	0.992
T26-T28 Burns and corrosions confined to eye and internal organs	0.008	0.992
T20-T25 Burns and corrosions of external body surface, specified by site	0.008	0.992
T00-T07 Injuries involving multiple body regions	0.008	0.992
S10-S19 Injuries to the neck	0.008	0.992
L81.8 Other specified disorders of pigmentation	0.008	0.992
L91.9 Hypertrophic disorder of skin, unspecified	0.008	0.992
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.008	0.992
T15-T19 Effects of foreign body entering through natural orifice	0.008	0.992
L91.0 Keloid scar	0.008	0.992
S70 Superficial injury of hip and thigh	0.008	0.992
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.008	0.992
T40.8 Lysergide [LSD]	0.008	0.992
T40.7 Cannabis (derivatives)	0.008	0.992
T40.6 Other and unspecified narcotics	0.008	0.992
T40.5 Cocaine	0.008	0.992
T40.4 Other synthetic narcotics	0.008	0.992
T40.3 Methadone	0.008	0.992
T40.1 Heroin	0.008	0.992
T40.0 Opium	0.008	0.992
L89.1 Stage II decubitus ulcer	0.008	0.992
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.008	0.992
L85.9 Epidermal thickening, unspecified	0.008	0.992
S69 Other and unspecified injuries of wrist and hand	0.008	0.992
T93 Sequelae of injuries of lower limb	0.008	0.992
T92 Sequelae of injuries of upper limb	0.008	0.992
L53.9 Erythematous condition, unspecified	0.008	0.992
L10-L14 Bullous disorders	0.008	0.992
L60.8 Other nail disorders	0.008	0.992
S31 Open wound of abdomen, lower back and pelvis	0.008	0.992
S66 Injury of muscle and tendon at wrist and hand level	0.008	0.992
S49 Other and unspecified injuries of shoulder and upper arm	0.008	0.992
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.008	0.992
L89.3 Stage IV decubitus ulcer	0.008	0.992
T79-T79 Certain early complications of trauma	0.008	0.992
T66-T78 Other and unspecified effects of external causes	0.008	0.992
S41 Open wound of shoulder and upper arm	0.008	0.992
S67 Crushing injury of wrist and hand	0.008	0.992
S65 Injury of blood vessels at wrist and hand level	0.008	0.992
S60 Superficial injury of wrist and hand	0.008	0.992
L98.8 Other specified disorders of skin and subcutaneous tissue	0.008	0.992
L00-L08 Infections of the skin and subcutaneous tissue	0.008	0.992
S62.8 Fracture of other and unspecified parts of wrist and hand	0.008	0.992
T38.9 Other and unspecified hormone antagonists	0.007	0.992
T38.8 Other and unspecified hormones and their synthetic substitutes	0.007	0.992
T38.7 Androgens and anabolic congeners	0.007	0.992
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.007	0.992
T38.5 Other oestrogens and progestogens	0.007	0.992
T38.4 Oral contraceptives	0.007	0.992
T38.2 Antithyroid drugs	0.007	0.992
T38.1 Thyroid hormones and substitutes	0.007	0.992
T38.0 Glucocorticoids and synthetic analogues	0.007	0.992
S62.6 Fracture of other finger	0.008	0.992
S64.0 Injury of ulnar nerve at wrist and hand level	0.007	0.992
L89.9 Decubitus ulcer and pressure area, unspecified	0.007	0.992
S46 Injury of muscle and tendon at shoulder and upper arm level	0.007	0.992
S68 Traumatic amputation of wrist and hand	0.007	0.992
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.007	0.992
T98 Sequelae of other and unspecified effects of external causes	0.007	0.992
T95 Sequelae of burns, corrosions and frostbite	0.007	0.992
T94 Sequelae of injuries involving multiple and unspecified body regions	0.007	0.992
T91 Sequelae of injuries of neck and trunk	0.007	0.992
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.007	0.992
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.007	0.992
S32 Fracture of lumbar spine and pelvis	0.007	0.992
K92.0 Haematemesis	0.008	0.992
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.007	0.992
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.007	0.992
S92 Fracture of foot, except ankle	0.007	0.992
S62.30 Fracture of other metacarpal bone (closed)	0.007	0.993
T90.9 Sequelae of unspecified injury of head	0.007	0.993
S40 Superficial injury of shoulder and upper arm	0.007	0.993
S91 Open wound of ankle and foot	0.007	0.993
T90.4 Sequelae of injury of eye and orbit	0.007	0.993
L54 Erythema in diseases classified elsewhere	0.007	0.993
L51 Erythema multiforme	0.007	0.993
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.007	0.993
L90.9 Atrophic disorder of skin, unspecified	0.007	0.993
L90.8 Other atrophic disorders of skin	0.007	0.993
L90.6 Striae atrophicae	0.007	0.993
L90.4 Acrodermatitis chronica atrophicans	0.007	0.993
L90.3 Atrophoderma of Pasini and Pierini	0.007	0.993
L90.2 Anetoderma of Jadassohn-Pellizzari	0.007	0.993
L90.1 Anetoderma of Schweninger-Buzzi	0.007	0.993
T51 Toxic effect of alcohol	0.007	0.993
S80-S89 Injuries to the knee and lower leg	0.007	0.993
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.007	0.993
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.993
T42.3 Barbiturates	0.007	0.993
T42.2 Succinimides and oxazolidinediones	0.007	0.993
T42.1 Iminostilbenes	0.007	0.993
T42.0 Hydantoin derivatives	0.007	0.993
T36.9 Systemic antibiotic, unspecified	0.007	0.993
T36.8 Other systemic antibiotics	0.007	0.993
T36.7 Antifungal antibiotics, systemically used	0.007	0.993
T36.6 Rifamycins	0.007	0.993
T36.5 Aminoglycosides	0.007	0.993
T36.4 Tetracyclines	0.007	0.993
T36.3 Macrolides	0.007	0.993
T36.2 Chloramphenicol group	0.007	0.993
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993
T36.0 Penicillins	0.007	0.993
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993
T37.5 Antiviral drugs	0.007	0.993
T37.4 Anthelminthics	0.007	0.993
T37.3 Other antiprotozoal drugs	0.007	0.993
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993
T37.1 Antimycobacterial drugs	0.007	0.993
T37.0 Sulphonamides	0.007	0.993
T41.5 Therapeutic gases	0.007	0.993
T41.4 Anaesthetic, unspecified	0.007	0.993
T41.3 Local anaesthetics	0.007	0.993
T41.2 Other and unspecified general anaesthetics	0.007	0.993
T41.1 Intravenous anaesthetics	0.007	0.993
T41.0 Inhaled anaesthetics	0.007	0.993
T45.9 Primarily systemic and haematological agent, unspecified	0.007	0.993
T45.8 Other primarily systemic and haematological agents	0.007	0.993
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993
T45.6 Fibrinolysis-affecting drugs	0.007	0.993
T45.5 Anticoagulants	0.007	0.993
T45.4 Iron and its compounds	0.007	0.993
T45.3 Enzymes, not elsewhere classified	0.007	0.993
T45.2 Vitamins, not elsewhere classified	0.007	0.993
T45.1 Antineoplastic and immunosuppressive drugs	0.007	0.993
T45.0 Antiallergic and antiemetic drugs	0.007	0.993
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993
T47.7 Emetics	0.007	0.993
T47.6 Antidiarrhoeal drugs	0.007	0.993
T47.5 Digestants	0.007	0.993
T47.4 Other laxatives	0.007	0.993
T47.3 Saline and osmotic laxatives	0.007	0.993
T47.2 Stimulant laxatives	0.007	0.993
T47.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993
T48.6 Antiasthmatics, not elsewhere classified	0.007	0.993
T48.5 Anti-common-cold drugs	0.007	0.993
T48.4 Expectorants	0.007	0.993
T48.3 Antitussives	0.007	0.993
T48.2 Other and unspecified agents primarily acting on muscles	0.007	0.993
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993
T48.0 Oxytocic drugs	0.007	0.993
T49.9 Topical agent, unspecified	0.007	0.993
T49.8 Other topical agents	0.007	0.993
T49.7 Dental drugs, topically applied	0.007	0.993
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993
T49.5 Ophthalmological drugs and preparations	0.007	0.993
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993
T49.3 Emollients, demulcents and protectants	0.007	0.993
T49.2 Local astringents and local detergents	0.007	0.993
T49.1 Antipruritics	0.007	0.993
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993
L60.0 Ingrowing nail	0.007	0.993
L50 Urticaria	0.007	0.993
L84 Corns and callosities	0.007	0.993
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.993
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.993
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.993
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.993
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.993
T44.0 Anticholinesterase agents	0.007	0.993
L71 Rosacea	0.007	0.993
S50 Superficial injury of forearm	0.007	0.993
S48 Traumatic amputation of shoulder and upper arm	0.007	0.993
S45 Injury of blood vessels at shoulder and upper arm level	0.007	0.993
S44 Injury of nerves at shoulder and upper arm level	0.007	0.993
S47 Crushing injury of shoulder and upper arm	0.007	0.993
S71 Open wound of hip and thigh	0.007	0.993
S62.5 Fracture of thumb	0.007	0.993
L08 Other local infections of skin and subcutaneous tissue	0.007	0.993
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993
S70.9 Superficial injury of hip and thigh, unspecified	0.007	0.993
K92 Other diseases of digestive system	0.007	0.993
S62.7 Multiple fractures of fingers	0.007	0.993
S62.4 Multiple fractures of metacarpal bones	0.007	0.993
S62.2 Fracture of first metacarpal bone	0.007	0.993
S62.1 Fracture of other carpal bone(s)	0.007	0.993
S62.0 Fracture of navicular [scaphoid] bone of hand	0.007	0.993
L85.3 Xerosis cutis	0.007	0.993
L85.2 Keratosis punctata (palmaris et plantaris)	0.007	0.993
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.007	0.993
L85.0 Acquired ichthyosis	0.007	0.993
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.007	0.993
S37 Injury of urinary and pelvic organs	0.007	0.993
S36 Injury of intra-abdominal organs	0.007	0.993
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.007	0.993
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.007	0.993
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.007	0.993
L81.7 Pigmented purpuric dermatosis	0.007	0.993
L81.6 Other disorders of diminished melanin formation	0.007	0.993
L81.5 Leukoderma, not elsewhere classified	0.007	0.993
L81.3 Cafe au lait spots	0.007	0.993
L81.2 Freckles	0.007	0.993
L81.1 Chloasma	0.007	0.993
L81.0 Postinflammatory hyperpigmentation	0.007	0.993
L60.9 Nail disorder, unspecified	0.007	0.993
L60.5 Yellow nail syndrome	0.007	0.993
L60.4 Beau's lines	0.007	0.993
L60.3 Nail dystrophy	0.007	0.993
L60.2 Onychogryphosis	0.007	0.993
L60.1 Onycholysis	0.007	0.993
S64.9 Injury of unspecified nerve at wrist and hand level	0.007	0.993
S64.8 Injury of other nerves at wrist and hand level	0.007	0.993
S64.7 Injury of multiple nerves at wrist and hand level	0.007	0.993
S64.3 Injury of digital nerve of thumb	0.007	0.993
S64.2 Injury of radial nerve at wrist and hand level	0.007	0.993
S64.1 Injury of median nerve at wrist and hand level	0.007	0.993
L81.4 Other melanin hyperpigmentation	0.007	0.993
L08.8 Other specified local infections of skin and subcutaneous tissue	0.007	0.993
L85.8 Other specified epidermal thickening	0.007	0.993
T39.0 Salicylates	0.007	0.993
S99 Other and unspecified injuries of ankle and foot	0.007	0.993
S98 Traumatic amputation of ankle and foot	0.007	0.993
S97 Crushing injury of ankle and foot	0.007	0.993
S96 Injury of muscle and tendon at ankle and foot level	0.007	0.993
S95 Injury of blood vessels at ankle and foot level	0.007	0.993
S94 Injury of nerves at ankle and foot level	0.007	0.993
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.007	0.993
S90 Superficial injury of ankle and foot	0.007	0.993
K92.1 Melaena	0.007	0.993
T90.2 Sequelae of fracture of skull and facial bones	0.007	0.993
L90.5 Scar conditions and fibrosis of skin	0.007	0.993
S22 Fracture of rib(s), sternum and thoracic spine	0.007	0.993
S78 Traumatic amputation of hip and thigh	0.007	0.993
S77 Crushing injury of hip and thigh	0.007	0.993
S76 Injury of muscle and tendon at hip and thigh level	0.007	0.993
S75 Injury of blood vessels at hip and thigh level	0.007	0.993
S74 Injury of nerves at hip and thigh level	0.007	0.993
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.007	0.993
S31.1 Open wound of abdominal wall	0.007	0.993
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.007	0.993
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993
T39.2 Pyrazolone derivatives	0.007	0.993
S30 Superficial injury of abdomen, lower back and pelvis	0.007	0.993
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.007	0.993
T65 Toxic effect of other and unspecified substances	0.007	0.993
T63 Toxic effect of contact with venomous animals	0.007	0.993
T62 Toxic effect of other noxious substances eaten as food	0.007	0.993
T61 Toxic effect of noxious substances eaten as seafood	0.007	0.993
T60 Toxic effect of pesticides	0.007	0.993
T59 Toxic effect of other gases, fumes and vapours	0.007	0.993
T57 Toxic effect of other inorganic substances	0.007	0.993
T56 Toxic effect of metals	0.007	0.993
T54 Toxic effect of corrosive substances	0.007	0.993
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.007	0.993
T52 Toxic effect of organic solvents	0.007	0.993
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.007	0.993
T58 Toxic effect of carbon monoxide	0.007	0.993
T55 Toxic effect of soaps and detergents	0.007	0.993
T50.8 Diagnostic agents	0.006	0.993
T50.7 Analeptics and opioid receptor antagonists	0.006	0.993
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.993
T50.5 Appetite depressants	0.006	0.993
T50.4 Drugs affecting uric acid metabolism	0.006	0.993
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.993
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.993
T50.1 Loop [high-ceiling] diuretics	0.006	0.993
T50.0 Mineralocorticoids and their antagonists	0.006	0.993
T90.8 Sequelae of other specified injuries of head	0.007	0.993
T90.5 Sequelae of intracranial injury	0.007	0.993
T90.3 Sequelae of injury of cranial nerves	0.007	0.993
T90.1 Sequelae of open wound of head	0.007	0.993
T90.0 Sequelae of superficial injury of head	0.007	0.993
K51.2 Ulcerative (chronic) proctitis	0.007	0.993
K90-K93 Other diseases of the digestive system	0.007	0.993
S70.0 Contusion of hip	0.007	0.993
S42 Fracture of shoulder and upper arm	0.006	0.993
L81.9 Disorder of pigmentation, unspecified	0.006	0.993
K51.0 Ulcerative (chronic) enterocolitis	0.007	0.993
S49.9 Unspecified injury of shoulder and upper arm	0.006	0.993
S79 Other and unspecified injuries of hip and thigh	0.006	0.993
L53.8 Other specified erythematous conditions	0.006	0.993
L53.3 Other chronic figurate erythema	0.006	0.993
L53.2 Erythema marginatum	0.006	0.993
L53.1 Erythema annulare centrifugum	0.006	0.993
L53.0 Toxic erythema	0.006	0.993
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.993
K51 Ulcerative colitis	0.007	0.993
L97 Ulcer of lower limb, not elsewhere classified	0.006	0.993
L40-L45 Papulosquamous disorders	0.006	0.993
S32.7 Multiple fractures of lumbar spine and pelvis	0.006	0.993
L98.7 Excessive and redundant skin and subcutaneous tissue	0.006	0.993
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.006	0.993
L98.5 Mucinosis of skin	0.006	0.993
L98.4 Chronic ulcer of skin, not elsewhere classified	0.006	0.993
L98.3 Eosinophilic cellulitis [Wells]	0.006	0.993
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.006	0.993
L98.1 Factitial dermatitis	0.006	0.993
L87.9 Transepidermal elimination disorder, unspecified	0.006	0.993
L87.8 Other transepidermal elimination disorders	0.006	0.993
L87.2 Elastosis perforans serpiginosa	0.006	0.993
L87.1 Reactive perforating collagenosis	0.006	0.993
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]	0.006	0.993
L93.2 Other local lupus erythematosus	0.006	0.993
L93.1 Subacute cutaneous lupus erythematosus	0.006	0.993
L93.0 Discoid lupus erythematosus	0.006	0.993
L94.9 Localised connective tissue disorder, unspecified	0.006	0.993
L94.8 Other specified localised connective tissue disorders	0.006	0.993
L94.6 Ainhum	0.006	0.993
L94.5 Poikiloderma vasculare atrophicans	0.006	0.993
L94.4 Gottron's papules	0.006	0.993
L94.3 Sclerodactyly	0.006	0.993
L94.2 Calcinosis cutis	0.006	0.993
L94.1 Linear scleroderma	0.006	0.993
L94.0 Localised scleroderma [morphea]	0.006	0.993
L95.9 Vasculitis limited to skin, unspecified	0.006	0.993
L95.8 Other vasculitis limited to skin	0.006	0.993
L95.1 Erythema elevatum diutinum	0.006	0.993
L95.0 Livedoid vasculitis	0.006	0.993
L98.0 Pyogenic granuloma	0.006	0.993
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.006	0.993
L99.0 Amyloidosis of skin	0.006	0.993
T93.9 Sequelae of unspecified injury of lower limb	0.006	0.993
L05 Pilonidal cyst	0.006	0.993
S50.9 Superficial injury of forearm, unspecified	0.006	0.994
T92.1 Sequelae of fracture of arm	0.006	0.994
S20 Superficial injury of thorax	0.006	0.994
S29 Other and unspecified injuries of thorax	0.006	0.994
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.006	0.994
S26 Injury of heart	0.006	0.994
S25 Injury of blood vessels of thorax	0.006	0.994
S24 Injury of nerves and spinal cord at thorax level	0.006	0.994
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.006	0.994
S21 Open wound of thorax	0.006	0.994
S92.0 Fracture of calcaneus	0.006	0.994
S41.1 Open wound of upper arm	0.006	0.994
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.006	0.994
T68 Hypothermia	0.006	0.994
L62.8 Nail disorders in other diseases classified elsewhere	0.006	0.994
L62.0 Clubbed nail pachydermoperiostosis	0.006	0.994
L63.9 Alopecia areata, unspecified	0.006	0.994
L63.8 Other alopecia areata	0.006	0.994
L63.2 Ophiasis	0.006	0.994
L63.1 Alopecia universalis	0.006	0.994
L63.0 Alopecia (capitis) totalis	0.006	0.994
L64.9 Androgenic alopecia, unspecified	0.006	0.994
L64.8 Other androgenic alopecia	0.006	0.994
L64.0 Drug-induced androgenic alopecia	0.006	0.994
L65.9 Nonscarring hair loss, unspecified	0.006	0.994
L65.8 Other specified nonscarring hair loss	0.006	0.994
L65.2 Alopecia mucinosa	0.006	0.994
L65.1 Anagen effluvium	0.006	0.994
L65.0 Telogen effluvium	0.006	0.994
L66.9 Cicatricial alopecia, unspecified	0.006	0.994
L66.8 Other cicatricial alopecia	0.006	0.994
L66.4 Folliculitis ulerythematosa reticulata	0.006	0.994
L66.3 Perifolliculitis capitis abscedens	0.006	0.994
L66.2 Folliculitis decalvans	0.006	0.994
L66.1 Lichen planopilaris	0.006	0.994
L66.0 Pseudopelade	0.006	0.994
L67.9 Hair colour and hair shaft abnormality, unspecified	0.006	0.994
L67.8 Other hair colour and hair shaft abnormalities	0.006	0.994
L67.1 Variations in hair colour	0.006	0.994
L67.0 Trichorrhexis nodosa	0.006	0.994
L68.9 Hypertrichosis, unspecified	0.006	0.994
L68.8 Other hypertrichosis	0.006	0.994
L68.3 Polytrichia	0.006	0.994
L68.2 Localised hypertrichosis	0.006	0.994
L68.1 Acquired hypertrichosis lanuginosa	0.006	0.994
L68.0 Hirsutism	0.006	0.994
L70.9 Acne, unspecified	0.006	0.994
L70.8 Other acne	0.006	0.994
L70.5 Acne excoriee des jeunes filles	0.006	0.994
L70.4 Infantile acne	0.006	0.994
L70.3 Acne tropica	0.006	0.994
L70.2 Acne varioliformis	0.006	0.994
L70.1 Acne conglobata	0.006	0.994
L70.0 Acne vulgaris	0.006	0.994
L74.9 Eccrine sweat disorder, unspecified	0.006	0.994
L74.8 Other eccrine sweat disorders	0.006	0.994
L74.4 Anhidrosis	0.006	0.994
L74.3 Miliaria, unspecified	0.006	0.994
L74.2 Miliaria profunda	0.006	0.994
L74.1 Miliaria crystallina	0.006	0.994
L74.0 Miliaria rubra	0.006	0.994
L75.9 Apocrine sweat disorder, unspecified	0.006	0.994
L75.8 Other apocrine sweat disorders	0.006	0.994
L75.2 Apocrine miliaria	0.006	0.994
L75.1 Chromhidrosis	0.006	0.994
L75.0 Bromhidrosis	0.006	0.994
S59 Other and unspecified injuries of forearm	0.006	0.994
S58 Traumatic amputation of forearm	0.006	0.994
S57 Crushing injury of forearm	0.006	0.994
S56 Injury of muscle and tendon at forearm level	0.006	0.994
S55 Injury of blood vessels at forearm level	0.006	0.994
S54 Injury of nerves at forearm level	0.006	0.994
S53 Dislocation, sprain and strain of joints and ligaments of elbow	0.006	0.994
H90-H95 Other disorders of ear	0.006	0.994
L73.9 Follicular disorder, unspecified	0.006	0.994
L73.8 Other specified follicular disorders	0.006	0.994
L73.1 Pseudofolliculitis barbae	0.006	0.994

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations